Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C news

Show

From To
New hepatitis C infections among HIV-positive gay men drop by half after direct-acting antiviral roll-out in Netherlands

A little more than a year after the Netherlands instituted a policy allowing unrestricted access to direct-acting antivirals for the treatment of hepatitis C, researchers have already

Published
17 February 2017
By
Liz Highleyman
Bridging gaps in hepatitis C awareness and diagnosis

If ever there was an area of healthcare where place-based care could have a major impact on local public health gains it is the identification and treatment of hepatitis C virus (HCV) infected patients. However the same reasons that point to place-based health systems being of value for this condition also make it one of the most difficult challenges to take on. If place-based care can be made to work for treating HCV it can be made to work across the system.

Published
10 February 2017
From
New Local Government Network
Initial HCV test results are false positive in almost half of general population

Nearly half of patients in the general population who test positive for hepatitis C virus (HCV) do not have the disease, according to Dr. Anne Moorman and her associates.

Published
08 February 2017
From
Family Practice News
Slamming booklet uses provocative 'Tom of Finland' images in safer injecting guide for gay men

This publication is adapted from a groundbreaking Dutch publication Slammen Do’s and Don’ts first published by Mainline Foundation in January 2016. The UK edition was adapted by Andrew Preston and Roy Jones, and superbly illustrated in the style of Tom of Finland by Michael Linnell.

Published
06 February 2017
From
Exchange Supplies
High hepatitis C prevalence seen in Amsterdam PrEP study participants

Researchers from the Dutch pre-exposure prophylaxis (PrEP) demonstration study, AmPrEP, have found an unexpectedly high rate of hepatitis C virus (HCV) infection in participants tested

Published
06 February 2017
By
Gus Cairns
Curing hepatitis C reduces the risk of diabetes & kidney failure in people with HIV/HCV co-infection

Curing hepatitis C infection substantially reduces the risk of developing type 2 diabetes in people with HIV/hepatitis C virus (HCV) co-infection, but does not reduce

Published
01 February 2017
By
Keith Alcorn
HCV eradication in HIV coinfected patients linked to reduced diabetes, chronic renal failure

Eradication of hepatitis C virus infection among patients coinfected with HIV was associated with reductions in diabetes and chronic renal failure in addition to reduced mortality, HIV progression and liver-related events, according to the results of a Spanish cohort study. These findings led investigators to conclude that HIV coinfected patients should receive HCV therapy regardless of their fibrosis stage.

Published
31 January 2017
From
Healio
Report Cites Liver Failure Risk With New Hepatitis C Drugs

A new report questions the safety of some of the new drugs found to cure hepatitis C, in light of findings of liver failure and injury. But hepatitis C virus (HCV) experts say the findings are inconclusive, should be interpreted with great caution, and should not influence prescribing.

Published
31 January 2017
From
Medscape
Liver cirrhosis and decompensation still on the rise among people with hepatitis C

Complications of advanced liver disease including cirrhosis and hepatic decompensation have risen over the past decade among people with chronic hepatitis C, according to study

Published
31 January 2017
By
Liz Highleyman
Final yes from NICE for Gilead’s Epclusa

The National Institute for Health and Care Excellence has now published final guidance endorsing Epclusa as an option for the treatment of adults with chronic hepatitis C genotype 1-6 infection on the NHS in England and Wales.

Published
27 January 2017
From
Pharma Times
← First12345...168Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.